
The Gates Foundation trust is heavily concentrated in three low-tech, wide-moat names—Berkshire Hathaway (29.3% of the portfolio), Waste Management (17.1%), and Canadian National Railway (13.6%)—after selling roughly two-thirds of its Microsoft stake. Recent operating highlights include Berkshire underwriting earnings rising to $3.2 billion in Q3 (from $1 billion a year earlier) while the shares trade at ~1.55x book; Waste Management reported a 32% adjusted operating margin and trades at ~15x expected EBITDA; Canadian National posted a 38.6% operating margin, ~14% free-cash-flow growth year-to-date, and an enterprise value near 12x analysts' EBITDA. The piece frames these holdings as defensive, predictable value investments with steady cash returns (dividends and buybacks) and attractive relative valuations for long-term investors.
Market structure: The Gates Foundation concentration (≈60% in three names; BRK ~29%, WM ~17%, CNI ~14%) amplifies outperformance of defensive, high-barrier businesses—winners: WM (landfill scarcity, 32% adj. margin) and CNI (38.6% margin, durable contracts); losers: high-beta cyclicals and new entrants in waste/rail. Pricing power should stay intact—WM can raise pricing annually and CNI can tighten yields on long-haul freight—implying steady cashflow growth versus GDP-sensitive peers. Cross-asset: flows into these defensive equities typically lower equity volatility and modestly tighten IG credit spreads, while commodity exposure (petroleum/chemicals/grain) keeps CNI's revenue correlated to soft commodities and FX between CAD/USD. Risk assessment: Tail risks include sudden regulatory shifts on landfill permitting or rail rate regulation, a major wildfire/operational disaster at WM, a national rail strike, or a material sell-down by the foundation; any of these could trigger >20% swings. Time horizon: immediate (days) — sentiment swings around Buffett/Gates headlines; short-term (weeks–months) — Q4 earnings and CNI 2026 capex guide; long-term (quarters–years) — Stericycle synergies and sustained free cash flow conversion. Hidden dependencies: Gates’ MSFT divestiture reduces tech liquidity and may force rebalancing into large-cap defensives, creating price support but also concentration risk. Trade implications: Favor tactical overweight in WM and CNI vs underweight BRK.B. Valuation edge: CNI ~12x EV/EBITDA vs peer ~14x; WM ~15x EV/EBITDA with margin expansion upside from Health Solutions—expect 12–24 month total-return targets of +15–30% if execution holds. Use 6–12 month call spreads to lever upside and 3–6 month puts as tail hedges around earnings/capex prints. Rotate out of cyclical transport and select industrials into these two names to lower portfolio beta. Contrarian angles: Consensus downplays concentration risk—if Gates continues redeploying MSFT proceeds, WM/CNI could face eventual rebalancing pressure; that makes BRK short-term supply of BRK.B shares likely to persist. The market may be under-pricing regulatory risk to landfills and rail tariffs—a 5–10% hit to volume or a 200–300bp margin compression would materially change upside. Historical parallel: large foundation divestitures (big-tech selloffs in early 2000s) created 3–6 month windows to buy quality cyclicals on weakness; opportunistic entry on 8–12% pullbacks is prudent.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment